D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
CALL
Meritage Homes
MTH
$4.78B
| $2.55M | ﹤0.01% |
+52,600
| New | +$2.71M |
|
|
TWOU
2652
CALL
DELISTED
2U Inc
TWOU
| $2.55M | ﹤0.01% |
2,533
+1,206
| +91% | +$1.41M |
|
2653
PUT
Shift4
FOUR
$4.45B
| $2.55M | ﹤0.01% |
+32,900
| New | +$2.84M |
|
2654
National Fuel Gas
NFG
$7.69B
| $2.55M | ﹤0.01% |
+48,561
| New | +$2.52M |
|
|
SSAA
2655
DELISTED
Science Strategic Acquisition Corp. Alpha Class A Common Stock
SSAA
| $2.55M | ﹤0.01% |
262,601
+80,971
| +45% | +$786K |
|
|
BBLN
2656
DELISTED
Babylon Holdings Limited
BBLN
| $2.55M | ﹤0.01% |
10,221
| – | – |
|
|
HCNEU
2657
DELISTED
Jaws Hurricane Acquisition Corp. Unit
HCNEU
| $2.54M | ﹤0.01% |
254,635
-145,365
| -36% | -$1.45M |
|
2658
PUT
Vital Farms
VITL
$586M
| $2.54M | ﹤0.01% |
144,700
+84,700
| +141% | +$1.52M |
|
2659
CALL
Edison International
EIX
$30.3B
| $2.54M | ﹤0.01% |
+45,800
| New | +$2.63M |
|
2660
ORIX
IX
$42.7B
| $2.53M | ﹤0.01% |
133,915
-46,000
| -26% | -$847K |
|
2661
Ryan Specialty Holdings
RYAN
$6.02B
| $2.53M | ﹤0.01% |
+74,759
| New | +$2.36M |
|
2662
Kura Oncology
KURA
$793M
| $2.53M | ﹤0.01% |
135,005
-164,005
| -55% | -$3.09M |
|
2663
CALL
Bath & Body Works
BBWI
$3.97B
| $2.53M | ﹤0.01% |
40,100
+2,990
| +8% | +$190K |
|
2664
Regenxbio
RGNX
$616M
| $2.53M | ﹤0.01% |
60,303
-201,467
| -77% | -$7.25M |
|
|
CPE
2665
PUT
DELISTED
Callon Petroleum Company
CPE
| $2.53M | ﹤0.01% |
51,500
+15,700
| +44% | +$608K |
|
|
EPIX
2666
DELISTED
ESSA Pharma
EPIX
| $2.53M | ﹤0.01% |
+315,731
| New | +$5.02M |
|
|
GGGV
2667
DELISTED
G3 VRM Acquisition Corp. Class A Common Stock
GGGV
| $2.52M | ﹤0.01% |
+252,026
| New | +$2.5M |
|
2668
Team
TISI
$80.6M
| $2.51M | ﹤0.01% |
83,503
+46,463
| +125% | +$2.24M |
|
2669
O-I Glass
OI
$1.18B
| $2.51M | ﹤0.01% |
176,098
-42,470
| -19% | -$636K |
|
|
OPLN
2670
Openlane
OPLN
$4.28B
| $2.51M | ﹤0.01% |
153,172
-151,652
| -50% | -$2.56M |
|
2671
CALL
Ryman Hospitality Properties
RHP
$8.56B
| $2.51M | ﹤0.01% |
30,000
| – | – |
|
2672
Apple Hospitality REIT
APLE
$3.97B
| $2.51M | ﹤0.01% |
159,424
-110,864
| -41% | -$1.66M |
|
2673
CALL
Everest Group
EG
$15.6B
| $2.51M | ﹤0.01% |
10,000
-10,600
| -51% | -$2.72M |
|
2674
Angi Inc
ANGI
$247M
| $2.5M | ﹤0.01% |
20,287
-42,885
| -68% | -$4.93M |
|
2675
AngioDynamics
ANGO
$605M
| $2.5M | ﹤0.01% |
96,397
-24,324
| -20% | -$650K |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.